Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model

Thomas J. Quinn, Ziqiang Yuan, Asha Adem, Rula Geha, Chakravarthy Vrikshajanani, Wade Koba, Eugene Fine, David T. Hughes, Herbert A. Schmid, Steven K. Libutti

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model'. Together they form a unique fingerprint.

Medicine & Life Sciences